Your browser doesn't support javascript.
loading
Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3ß pathway.
Sadek, Mohamed A; Kandil, Esraa A; El Sayed, Nesrine S; Sayed, Helmy M; Rabie, Mostafa A.
Afiliação
  • Sadek MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Kandil EA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • El Sayed NS; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Sayed HM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Rabie MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: Mostafa.mohammed@pharma.cu.edu.eg.
Int Immunopharmacol ; 115: 109647, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36584570
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Doenças Neurodegenerativas / Encefalomielite Autoimune Experimental / Esclerose Múltipla Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Doenças Neurodegenerativas / Encefalomielite Autoimune Experimental / Esclerose Múltipla Idioma: En Ano de publicação: 2023 Tipo de documento: Article